Sincalide |
Cholecystokinin octapeptide; CCK-8 |
(CAS 25126-32-3) |
 |
Description: |
Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin, and also known as CCK-8.
Common adverse effects following administration include abdominal discomfort and nausea. These effects are more pronounced following rapid infusion.
|
Product No. |
KT10076 |
Product Name |
Sincalide |
Synonyms |
Caerulein,1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine- (8CI);Cholecystokinin-8(pig);Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2;Cholecystokinin C-terminaloctapeptide;Cholecystokinin octapeptid |
Formal Name |
Cholecystokinin octapeptide; CCK-8 |
CAS Number |
25126-32-3 |
Molecular Formula |
C49H62N10O16S3 |
Formula Weight |
1143.27 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
Leuprorelin Acetate
Lipopeptide Acetate
Liraglutide
Lixisenatide
Lysipressin Acetate
Matrixyl
Melanotan II
Nafarelin Acetate
Nesiritide Acetate
Octreotide
Octreotide acetate
Ornipressin Acetate
Vapreotide Acetate
Vapreotide acetate
Vasopressin Acetate
Ziconotide acetate
|
|